Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Mar. 31, 2022 $ (126,683) $ 605 $ 645,038 $ (770,903) $ (1,423)
Beginning balance (in shares) at Mar. 31, 2022   60,433,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (10,220)     (10,220)  
Foreign currency translation adjustments, net (1,276)       (1,276)
Shares issued under employee incentive plans, net 0 $ 2 (2)    
Shares issued under employee stock purchase plan (in shares)   173,000      
Shares issued in connection with rights offering, net 66,323 $ 300 66,023    
Shares issued in connection with rights offering, net (in shares)   30,000,000      
Stock-based compensation 3,069   3,069    
Settlement of warrant down round provision 389   389    
Deemed dividend on warrants (389)   (389)    
Ending balance at Jun. 30, 2022 (68,787) $ 907 714,128 (781,123) (2,699)
Ending balance (in shares) at Jun. 30, 2022   90,606,000      
Beginning balance at Mar. 31, 2023 $ (86,888) $ 936 722,603 (808,846) (1,581)
Beginning balance (in shares) at Mar. 31, 2023 93,574,000 93,574,000      
Increase (Decrease) in Stockholders' Equity          
Net loss $ (10,576)     (10,576)  
Foreign currency translation adjustments, net 249       249
Shares issued under employee incentive plans, net 0 $ 2 (2)    
Shares issued under employee stock purchase plan (in shares)   131,000      
Stock-based compensation 1,901   1,901    
Deemed dividend on warrants 0        
Warrants Issued In Connection With Debt Refinancing 1,234   1,234    
Ending balance at Jun. 30, 2023 $ (94,080) $ 938 $ 725,736 $ (819,422) $ (1,332)
Ending balance (in shares) at Jun. 30, 2023 93,705,000 93,705,000